IGC Pharma (IGC) FCF Margin Growth (3y) (2013 - 2025)
IGC Pharma (IGC) FCF Margin Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5,426.00 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9,545.00 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4,612.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 14,060.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | -3,088.00 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1,850.00 |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -47,477.00 |
| Jun 30, 2025 | 66,435.00 |
| Mar 31, 2025 | 69,874.00 |
| Dec 31, 2024 | 116,296.00 |
| Sep 30, 2024 | 373,514.00 |
| Jun 30, 2024 | 186,659.00 |
| Mar 31, 2024 | 472,402.00 |
| Dec 31, 2023 | 89,706.00 |
| Sep 30, 2023 | 140,156.00 |
| Jun 30, 2023 | 41,477.00 |
| Mar 31, 2023 | 841,762.00 |
| Dec 31, 2022 | 36,060.00 |
| Sep 30, 2022 | -54,926.00 |
| Jun 30, 2022 | -92,056.00 |
| Mar 31, 2022 | -85,044.00 |
| Dec 31, 2021 | -158,202.00 |
| Sep 30, 2021 | -394,496.00 |
| Jun 30, 2021 | -248,827.00 |
| Mar 31, 2021 | -481,257.00 |
| Dec 31, 2020 | -166,266.00 |